MedTrace Logo

Improving Adherence and Clinical Outcome in Cystic Fibrosis (CF) Patients

NCT01025258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-09-04

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of a collaborative active intervention program of a multi-disciplinary team on improving adherence to chronic medications and improve clinical outcomes in CF patients.

Conditions

Interventions

BEHAVIORAL

Frequent Scheduled CF clinic visits

Mandatory scheduled visit at the CF clinic every 1-2 months or sooner, if needed, for an evaluation by a a specialized CF team member such as: a pulmonary physician, a gastroenterologist, a dietitian, a clinical pharmacist

BEHAVIORAL

frequent telephone calls to patients pre and post visits to the clinic

Frequent telephone calls for monitoring, educating and identifying barriers in adherence will be made by a designated CF team member such as the CF nurse or the CF clinical pharmacist.

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Ori Efrati, MD · Sheba Medical Center

  • Vardit M Kalamaro, BPharm, MSc · The Israeli Cystic Fibrosis Foundation

  • Ran Nissan, Pharm D Student · Hebrew University of Jerusalem

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01025258 on ClinicalTrials.gov